The mark consists in a figure of three green circles and the word "CELLTRION" in black, in which said three green circles have a thin-lined circle, a thick-lined circle and a solid circle.
Mark For: CELLTRION® trademark registration is intended to cover the categories of
>The color(s) black, green is/are claimed as a feature of the mark. The mark consists in a figure of three green circles and the word "CELLTRION" in black, in which said three green circles have a thin-lined circle, a thick-lined circle and a solid circle.
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 79101488 |
Registration Number | 4169803 |
Mark Literal Elements | CELLTRION |
Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
Mark Type | TRADEMARK. SERVICE MARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Affidavit Text | SECTION 71 |
Current Location | Not Found 2018-07-20 |
Basis | 66(a) |
Class Status | SECTION 71 - CANCE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | Yes |
Current Basis | No |
No Basis | No |
Cancellation Code | G |
Attorney Name | Kisuk Lee |
Attorney Docket Number | 15234-200009 |
Law Office Assigned | M60 |
Employee Name | COLEMAN, NICHOLAS A |
2011-04-01 | Application Filed |
2012-04-24 | Published |
2012-04-24 | Published for Opposition |
2012-07-10 | Trademark Registered |
2018-07-20 | Location: |
2018-07-20 | Location: Not Found |
2018-07-20 | Status: A partial Section 71 declaration has been accepted. |
2018-07-20 | Status: Live/Registered |
2019-04-19 | Transaction Date |
2021-07-10 | Maintenance Early File Date |
2022-07-11 | Maintenance On Time Date |
2023-01-10 | Maintenance Late Fee Date |
Party: | ![]() |
Address | 23, Academy-ro, Yeonsu-gu Incheon KOREA, REPUBLIC OF 406-840 |
Legal Entity Type | Corporation |
Legal Entity State | KOREA, REPUBLIC OF |
26.01.15 | Circles, exactly three circles; Three circles |
26.01.21 | Circles that are totally or partially shaded. |
260102 | Circles, plain single line; Plain single line circles |
260115 | Circles, exactly three circles; Three circles |
260121 | Circles that are totally or partially shaded. |
(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: [ Vaccines; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organ; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the peripheral nervous system; agents for immunity adjustment, namely, pharmaceutical preparations for the prevention and treatment of disorders of the immune system; biological preparations for medical purposes; amino acids for medical purposes; antibiotic preparations; agents for respiratory organs, namely, pharmaceutical preparations for the prevention and treatment of disorders of respiratory organs; chemotherapeutics; reagents for measuring Hepatitis B Surface antibody, namely, medical diagnostic reagents for detecting Hepatitis B surface antibody; diagnostic preparations for medical use; AIDS, acquired immune deficiency syndrome diagnostic agents, namely, diagnostic preparation for medical use; AIDS, acquired immune deficiency syndrome vaccines; agents affecting central nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the nervous system; veterinary vaccines; agents for tumor treatment, namely, pharmaceutical preparations for the treatment of tumor; agents for urogenital organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of urogenital organs; kits for protein test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a protein related to a disease; kits for gene test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a gene related to a disease; biopharmaceuticals for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; biopharmaceutical preparations, namely, polypeptides, proteins, monoclonal antibodies, hormones for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone deficiency diseases; biotherapeutic preparations and substances for medical purposes; biotechnological preparations for medical purposes; pharmaceuticals; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; chemico-pharmaceutical preparations ]
IC 035. US 100 101 102. G & S: Wholesale distributorships featuring pharmaceutical products; retail store services featuring pharmaceutical products; business intermediary services in the field of pharmaceutical products; wholesale distributorships featuring biopharmaceutical products; retail store services featuring biopharmaceutical products; business intermediary services in the field of biopharmaceutical products
IC 040. US 100 103 106. G & S: Treatment of biopharmaceutical materials, namely, processing finished products from raw biopharmaceutical materials; treatment service of biopharmaceutical materials for others, namely, processing finished products from raw biopharmaceutical materials for others; contract manufacturing service for others in the field of biopharmaceuticals; contract manufacturing service in the field of pharmaceuticals
IC 042. US 100 101. G & S: Pharmaceutical research and development; [ bacteriological research; biological research; research and development for new products for others; material testing; chemistry services, namely, chemistry consultation; chemical research and analysis; technology outsourcing services on biopharmaceuticals manufacturing, namely, conducting biopharmaceutical research services for others; consulting services in the field of biotechnology; pharmaceutical drug development services with animal cell; scientific research related to genetically modified plant; biotechnology research; ] biopharmaceutical research and development [; medical product testing; technology outsourcing services on selecting medicines, namely, conducting pharmaceutical research services for others ](CANCELLED)
IC 044. US 100 101. G & S: [ Rental of medical and health care equipment; medical product information, namely, providing an interactive holistic web site featuring health information and patient initiated, patient authorized, fee-for-service, holistic approach distance healing sessions based on the patient's specific set of symptoms, medical profile and medical record analysis and patient benefit information concerning organic and holistic products and services; medical clinics, namely, conducting clinical trials of new products for medical purposes; hospitals; medical assistance services; biopharmaceutical consulting service ]
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 35 |
U.S. Codes: | 100,101,102 |
International Codes: | 40 |
U.S. Codes: | 100,103,106 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
B00001 | Page 2, line 28 through 30, "medical product testing; technology outsourcing services on selecting medicines, namely, conducting pharmaceutical research services for others" should be deleted in class 42. |
Description | Date |
---|---|
![]() | 2015-03-26 |
Description | Date | Proceeding Number |
---|---|---|
PARTIAL INVALIDATION PROCESSED BY THE IB | 2019-04-19 | |
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | 2019-03-23 | |
INVALIDATION PROCESSED | 2019-03-23 | 72629 |
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | 2019-03-20 | |
REGISTERED - PARTIAL SEC 71 ACCEPTED | 2018-07-20 | 75461 |
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | 2018-07-20 | |
CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2018-07-18 | 75461 |
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2018-06-21 | |
TEAS SECTION 71 RECEIVED | 2018-06-21 | |
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | 2017-07-10 | |
CHANGE OF NAME/ADDRESS REC'D FROM IB | 2015-03-26 | |
LIMITATION FROM THE IB EXAMINED AND ENTERED | 2013-10-11 | 72589 |
CERTIFICATE OF CORRECTION ISSUED | 2013-10-11 | 76293 |
ASSIGNED TO PARALEGAL | 2013-10-11 | 76293 |
LIMITATION OF GOODS RECEIVED FROM IB | 2013-08-30 | |
NOTIFICATION PROCESSED BY IB | 2012-12-02 | |
FINAL DECISION TRANSACTION PROCESSED BY IB | 2012-11-04 | |
FINAL DISPOSITION PROCESSED | 2012-10-16 | 67445 |
FINAL DISPOSITION NOTICE SENT TO IB | 2012-10-16 | |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2012-10-10 | |
REGISTERED-PRINCIPAL REGISTER | 2012-07-10 | |
PUBLISHED FOR OPPOSITION | 2012-04-24 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2012-04-24 | |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2012-04-04 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2012-04-04 | |
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2012-04-04 | |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2012-03-19 | 74221 |
ASSIGNED TO LIE | 2012-03-19 | 74221 |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2012-03-02 | 6328 |
EXAMINERS AMENDMENT E-MAILED | 2012-03-02 | 6328 |
EXAMINERS AMENDMENT -WRITTEN | 2012-03-02 | 85330 |
EXAMINER'S AMENDMENT ENTERED | 2012-03-02 | 88888 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2012-03-02 | |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2011-12-15 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2011-12-15 | |
REFUSAL PROCESSED BY IB | 2011-10-18 | |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2011-09-23 | |
REFUSAL PROCESSED BY MPU | 2011-09-22 | 72589 |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2011-09-22 | |
NON-FINAL ACTION WRITTEN | 2011-09-21 | 85330 |
APPLICATION FILING RECEIPT MAILED | 2011-09-13 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2011-09-09 | |
ASSIGNED TO EXAMINER | 2011-09-09 | 85330 |
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2011-09-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.